Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.
Guangzhou Baiyunshan Pharmaceutical Holdings Company successfully held its second extraordinary general meeting (EGM) on 26 September 2025, where all proposed resolutions were approved by shareholders. The meeting, which adhered to the relevant legal and company provisions, saw participation from a significant portion of shareholders, indicating strong support for the company’s strategic decisions.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.50 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company with limited liability established in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
Average Trading Volume: 1,767,889
Technical Sentiment Signal: Buy
Current Market Cap: HK$43.12B
For detailed information about 0874 stock, go to TipRanks’ Stock Analysis page.